Alvogen wins partial victory in South Korean appeal for cancer drugs fine
Pharmaceutical company Alvogen secured a partial court victory today in its appeal challenging the antitrust fine imposed by South Korea’s competition regulator, with the court overturning parts of the corrective orders...To view the full article, register now.
Already a subscriber? Click here to view full article